Apollo Hospitals Enterprise Limited vs Rubicon Research Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Rubicon Research Limited (RUBICON) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs RUBICON on 8 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation40
  • Profitability13
  • Growth01
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

APOLLOHOSP takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
98.69
13.46
P/B ratio
23.00
0.22%
Dividend yield
0.08%
₹135.04
EPS
₹15.52

Profitability

RUBICON takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
19.14%
17.31%
Return on capital
22.67%
14.94%
EBITDA margin
22.82%
7.94%
Net margin
14.07%

Growth

RUBICON takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
64.50%
33.35%
Profit CAGR (3Y) even
—

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹25,016 Cr
₹25,229 Cr
Revenue
₹1,754 Cr
₹2,003 Cr
Net profit
₹247 Cr
0.90
Debt / equity
0.24
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Rubicon Research Limited
  • + ["Company has delivered good profit growth of 51.4% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 27.7%", "Company has delivered good sales growth of 41.0% CAGR over last 5 years"]
  • − ["Stock is trading at 19.41 times its book value"]
Apollo Hospitals Enterprise Limited full analysis Rubicon Research Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLOHOSP vs RUBICON: Share Price, Valuation & Which to Buy | DocStoX